KLK3 and prostate carcinoma: They have been extensively used to make predictions on the occurrence of a clinical event while accounting for an endogenous time-dependent covariate (the longitudinal outcome), for example predicting prostate cancer recurrence using PSA (prostate-specific antigen) measurements [3].